All updates
All updates
today 1STAT News评分1010 Nature Reviews Drug Discovery评分2222 Soft drugs: design principles and topical applications
STAT News评分1616 Opinion: STAT+: What to think about those mice with half-human brains
STAT News评分2222 Opinion: America’s biotech race with China must be won at home
BioSpace评分1616 Biopharma needs to reward scientists' judgment
BioSpace评分1717 Trend of women-led M&A fades in 2026 with just two deals so far
Nature评分2626 Lab-grown brain organoids: time for international oversight
Nature评分1010 A new chapter in targeting kinase enzymes in cancer
Nature评分77 Chinese-owned science journal created to rival the best
The Lancet Oncology精选评分4242 [Policy Review] Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer
STAT News评分1010 STAT+: At MAHA Summit, a grassroots movement goes corporate
监管与产业动态评分1414 The intrinsic, instrumental, and symbolic values of sustaining childhood vaccination in conflict settings
文献与产业新闻评分1313 The intrinsic, instrumental, and symbolic values of sustaining childhood vaccination in conflict settings
监管与产业动态评分2222 New opioid up to 10 times stronger than fentanyl spreading across US
BioSpace评分3131 6 immunology targets to sustain a mammoth I&I market
BioSpace评分2424 Regenerative medicine needs more than stem cells
STAT News评分2424 STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’
STAT News评分2121 Trump uses ‘contested’ power to cut more funding to HHS
STAT News评分77 STAT+: It really is bleak out there, and list prices matter
STAT News评分2121 Opinion: Child health is the national security crisis we keep ignoring
STAT News评分1515 STAT+: Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midterms
监管与产业动态评分1010 Big Pharma's Big Brand: Regeneron's science-driven communications approach - Fierce Pharma
The Lancet评分1313 [Correspondence] Declare the climate crisis a Public Health Emergency of International Concern
监管与产业动态评分1010 For Rare Disease Marketing, Precision Starts with the Care Pathway - Fierce Pharma
监管与产业动态评分2222 A new era of discovery for immunology: Expert Q& A
STAT News评分1414 Why MAHA wants to make health data much more accessible
STAT News评分1414 She’s spent two decades talking to parents who don’t vaccinate their children. Here’s what she’s learned
监管与产业动态评分1212 10 Keys to Commercializing Cell & Gene Therapies - Fierce Biotech
监管与产业动态评分1313 The Kush Drug Epidemic in Sierra Leone: Public Health Implications, Socioeconomic Drivers and Health System Responses
Nature评分2323 AI can widen science — but only if institutions stop rewarding the already measurable
文献与产业新闻评分99 The Kush Drug Epidemic in Sierra Leone: Public Health Implications, Socioeconomic Drivers and Health System Responses
Nature评分88 Biodiversity protection must include language preservation
Nature Reviews Drug Discovery评分3030 The cellular landscape of druggable RNA-binding proteins
监管与产业动态评分2323 The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact
文献与产业新闻评分2222 The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact
监管与产业动态评分1111 From Promise to Precision: The Next Chapter of Checkpoint Inhibition
Nature评分1616 PhD training should encourage ethical dissent
Nature Medicine精选评分2929 Reproducibility in biomedical research
Nature评分1717 Daily briefing: Vaping has ‘alarming’ risks for children
文献与产业新闻评分1515 From Promise to Precision: The Next Chapter of Checkpoint Inhibition